跳至主要内容
临床试验/NCT02977702
NCT02977702已完成不适用

Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma

Institut de Cancérologie de Lorraine0 个研究点目标入组 114 人开始时间: 2015年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
114
主要终点
overall survival

研究概览

简要总结

The primary objective of this study was to validate Total Psoas Area (TPA) measurement as an independent prognostic factor of overall survival in patients with pancreatic adenocarcinoma. Secondary objective was to describe the evolution of the TPA during the follow-up.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients consecutive enrolled from January 2009 to December 2015 who underwent at least one chemotherapy for pancreatic adenocarcinoma, whatever the stage

排除标准

  • A patient record captured outside the time frame from January 2009 to December 2015

结局指标

主要结局

overall survival

时间窗: 24 months

次要结局

未报告次要终点

研究者

发起方
Institut de Cancérologie de Lorraine
申办方类型
Other
责任方
Sponsor

相似试验